Table 2.
Correlation between serum endocannabinoids and blood pressure in depression
| AEA | 2-AG | ||||
|---|---|---|---|---|---|
| r* | P† | r | P | ||
| Control n = 27 | MAP | -.07 | 0.72 | -.06 | 0.78 |
| SBP | -.17 | 0.40 | .04 | 0.83 | |
| DBP | -.05 | 0.81 | -.04 | 0.84 | |
| HR | -.02 | 0.92 | -.13 | 0.54 | |
| Depressed patients n = 28 |
MAP | .50 | < 0.01‡ | .46 | 0.01‡ |
| SBP | .35 | 0.07 | .22 | 0.26 | |
| DBP | .46 | 0.01‡ | .62 | < 0.01‡ | |
| HR | .34 | 0.08 | .14 | 0.48 | |
* correlation coefficient as determined by Pearson correlation tests; † probability value; ‡ statistical significance; MAP, mean arterial blood pressure; SBP, systolic blood pressure; DBP, diastolic blood pressure; HR: heart rate